Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 290

1.

Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2007 Jan;30(1):38-42.

PMID:
17192330
2.

Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS.

Diabetes Care. 2006 Mar;29(3):643-9.

PMID:
16505520
3.

A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.

Sosenko JM, Krischer JP, Palmer JP, Mahon J, Cowie C, Greenbaum CJ, Cuthbertson D, Lachin JM, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2008 Mar;31(3):528-33. Epub 2007 Nov 13.

PMID:
18000175
4.

Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Mahon J, Greenbaum CJ, Cowie CC, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2009 Sep;32(9):1603-7. doi: 10.2337/dc08-2140. Epub 2009 Jun 1.

5.

Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.

Greenbaum CJ, Cuthbertson D, Krischer JP; Disease Prevention Trial of Type I Diabetes Study Group.

Diabetes. 2001 Feb;50(2):470-6.

6.

Predicting future cardiovascular disease: do we need the oral glucose tolerance test?

Stern MP, Fatehi P, Williams K, Haffner SM.

Diabetes Care. 2002 Oct;25(10):1851-6.

PMID:
12351490
7.

Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans.

McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY.

Diabetes Care. 2003 Mar;26(3):758-63.

PMID:
12610034
8.

Fasting proinsulin concentrations predict the development of type 2 diabetes.

Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN.

Diabetes Care. 1999 Feb;22(2):262-70.

9.

Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study.

Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L.

Diabetes Care. 2009 Feb;32(2):281-6. doi: 10.2337/dc08-1264. Epub 2008 Nov 18.

10.

Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?

Schatz D, Cuthbertson D, Atkinson M, Salzler MC, Winter W, Muir A, Silverstein J, Cook R, Maclaren N, She JX, Greenbaum C, Krischer J.

Pediatr Diabetes. 2004 Jun;5(2):72-9.

PMID:
15189492
12.

Prediction of diabetes with body mass index, oral glucose tolerance test and islet cell autoantibodies in a regional population.

Rolandsson O, Hägg E, Nilsson M, Hallmans G, Mincheva-Nilsson L, Lernmark A.

J Intern Med. 2001 Apr;249(4):279-88.

13.

Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes.

Moore MC, Davis SN, Mann SL, Cherrington AD.

Diabetes Care. 2001 Nov;24(11):1882-7.

PMID:
11679451
14.

[Critical evaluation of the oral glucose tolerance test for the diagnosis of insulin resistance in patients with polycystic ovary syndrome].

Calvar CE, Bengolea SV, Hermes R, Loyato M.

Medicina (B Aires). 2007;67(1):1-7. Spanish.

PMID:
17408014
15.

Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

Stern MP, Williams K, Haffner SM.

Ann Intern Med. 2002 Apr 16;136(8):575-81.

PMID:
11955025
16.

Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Matheson D, Skyler JS.

Diabetes Care. 2008 Nov;31(11):2188-92. doi: 10.2337/dc08-0935. Epub 2008 Jul 23.

17.

Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.

Valdés S, Botas P, Delgado E, Alvarez F, Cadórniga FD.

Metabolism. 2008 Mar;57(3):399-403. doi: 10.1016/j.metabol.2007.10.017.

PMID:
18249214
18.

The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.

Anderwald C, Anderwald-Stadler M, Promintzer M, Prager G, Mandl M, Nowotny P, Bischof MG, Wolzt M, Ludvik B, Kästenbauer T, Pacini G, Luger A, Krebs M.

Diabetes Care. 2007 Sep;30(9):2374-80. Epub 2007 Jun 26.

PMID:
17595351
19.

What is the best predictor of future type 2 diabetes?

Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M.

Diabetes Care. 2007 Jun;30(6):1544-8. Epub 2007 Mar 23.

PMID:
17384342
20.

A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history.

Sosenko JM, Skyler JS, DiMeglio LA, Beam CA, Krischer JP, Greenbaum CJ, Boulware D, Rafkin LE, Matheson D, Herold KC, Mahon J, Palmer JP; Type 1 Diabetes TrialNet Study Group; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2015 Feb;38(2):271-6. doi: 10.2337/dc14-1813. Epub 2014 Dec 17.

Supplemental Content

Support Center